PTJ
NEUE

Paul Tudor Jones’s NeueHealth NEUE Stock Holding History

Paul Tudor Jones’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,100
Closed -$1.4M – 2799
2021
Q4 		$1.4M Buy
5,100
+3,676
+258% +$1.7M 0.02% 822
2021
Q3 		$930K Sell
1,424
-2,277
-62% -$2M 0.02% 1208
2021
Q2 		$5.08M Buy
+3,701
New +$5.07M 0.1% 212

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Paul Tudor Jones's NEUE Position: Q1 2022 in Review

Paul Tudor Jones sold out of NeueHealth (NEUE) in Q1 2022, closing a stake of 5,100 shares — an estimated $1.4M sold.

Paul Tudor Jones first reported a position in NEUE in Q2 2021 and held it in 3 quarters. The position peaked at $5.08M in Q2 2021. 121 funds tracked by Wall St. Rank hold NEUE as of Q1 2022.

  • Paul Tudor Jones reported no remaining NeueHealth position as of Q1 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 5,100 NeueHealth shares in Q1 2022, an estimated $1.4M.
  • Paul Tudor Jones first reported a position in NeueHealth in Q2 2021 and held it in 3 quarters.
  • Paul Tudor Jones's NeueHealth position peaked at $5.08M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held NeueHealth as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.